TMT1B and cancer: METTL7B is positively correlated with OS and DFS in patients with low-grade glioma (LGG) and immune cell infiltration of LGG; and participates in extracellular matrix (ECM) and immune-related pathways in LGG, contributing to cell proliferation, cancer progression and EMT.